Skip to main content

Articles

Page 2 of 2

  1. The current treatment paradigm in head and neck cancer does not adequately address its clinical and biological heterogeneity. Data from genomic profiling studies in head and neck squamous cell carcinoma (HNSCC...

    Authors: Kyaw L. Aung and Lillian L. Siu

    Citation: Cancers of the Head & Neck 2016 1:2

    Content type: Review

    Published on:

  2. Human papillomavirus (HPV)-positive oropharyngeal cancer primarily affects working-age adults. Chemotherapy and radiation (CTRT) used to treat this disease may adversely impact a survivors’ ability to work aft...

    Authors: Shrujal S. Baxi, Talya Salz, Han Xiao, Coral L. Atoria, Alan Ho, Stephanie Smith-Marrone, Eric J. Sherman, Nancy Y. Lee, Elena B. Elkin and David G. Pfister

    Citation: Cancers of the Head & Neck 2016 1:4

    Content type: Research

    Published on:

  3. Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and is frequently impervious to curative treatment efforts. Similar to other cancers associated with prolonged exposure t...

    Authors: Tim N. Beck and Erica A. Golemis

    Citation: Cancers of the Head & Neck 2016 1:1

    Content type: Review

    Published on: